These results are suggestive of ABCB1 polymorphisms in AML likely influencing the efficacy of standard chemotherapy, specifically in relation to OS, where the variants could have a positive effect due to lower P-gp expression. The gene discussed is PGP; the disease is acute myeloid leukemia.